Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12;101(32):e29968.
doi: 10.1097/MD.0000000000029968.

Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome

Jun Hwan Kim  1   2 , Dae Yong Yi  1   2 , Yoo Min Lee  3 , You Jin Choi  2   4 , Ju Young Kim  5 , Yong Hee Hong  3 , Ji Young Park  1 , Su Yeong Kim  1 , Na Mi Lee  1   2 , Sin Weon Yun  1   2 , Soo Ahn Chae  1   2 , In Seok Lim  1   2 , Eung Sang Choi  6 , In Sook Jeong  7
Affiliations

Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome

Jun Hwan Kim et al. Medicine (Baltimore). .

Abstract

Irritable bowel syndrome (IBS) is a common pediatric functional gastrointestinal disorder. It is characterized by recurrent abdominal pain and changes in bowel habits and is more prevalent in obese patients. We investigated the association between obesity and IBS in pediatric patients through fecal calprotectin testing. Patients under 18 years of age with IBS who underwent fecal calprotectin testing from January 2015 through April 2020 were retrospectively investigated. The patients were divided into groups based on body mass index (BMI): group I (BMI < 85th percentile) and group II (BMI ≥ 85th percentile). Group II was divided into group IIa, overweight (85th percentile ≤ BMI < 95th percentile), and group IIb, obese (BMI ≥ 95th percentile). Among 277 included patients, 202 (72.9%) were in group I, and 75 (27.1%) were in group II (mean calprotectin levels, 75.60 ± 103.48 vs 45.89 ± 66.57 µg/g, respectively; P = .006). There were significant differences in mean calprotectin levels between groups I and IIa (75.60 ± 103.48 vs 45.45 ± 63.38 µg/g, respectively; P = .028) and groups I and IIb (75.60 ± 103.48 vs 46.22 ± 69.59 µg/g, respectively; P = .025). There was a significant difference in mean calprotectin levels between groups I and II (85.69 ± 142.13 vs 32.04 ± 28.17 µg/g, respectively; P = .029) among patients between 6 and 12 years of age but not among adolescents aged between 12 and 18 years (P = .139). Fecal calprotectin was lower when moderate-to-severe fatty livers were observed by ultrasound compared with normal livers (68.52 ± 97.22 vs 18.53 ± 18.56 µg/g, respectively; P = .017). Fecal calprotectin levels were higher in normal-weight pediatric IBS patients than in their obese counterparts, and this difference was more prominent in younger patients. In young children, IBS symptoms are thought to be influenced more by factors other than intestinal inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Flowchart of subject selection. BMI = body mass index.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Longstreth GF, Thompson WG, Chey WD, et al. . Functional bowel disorders. Gastroenterology. 2006;130:1480–91. - PubMed
    1. Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23:151–63. - PMC - PubMed
    1. Devanarayana NM, Rajindrajith S, Pathmeswaran A, et al. . Epidemiology of irritable bowel syndrome in children and adolescents in Asia. J Pediatr Gastroenterol Nutr. 2015;60:792–8. - PubMed
    1. Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211–35. - PMC - PubMed
    1. Son YJ, Jun EY, Park JH. Prevalence and risk factors of irritable bowel syndrome in Korean adolescent girls: a school-based study. Int J Nurs Stud. 2009;46:77–85. - PubMed

Substances